GIP
THTX

Greatmark Investment Partners’s Theratechnologies THTX Stock Holding History

Greatmark Investment Partners’s Portfolio THTX Stock Details THTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-11,250
Closed -$36.1K – 155
2025
Q3 		$36.1K Sell
11,250
-3,625
-24% -$11.6K ﹤0.01% 149
2025
Q2 		$35.1K Hold
14,875
– – ﹤0.01% 145
2025
Q1 		$20.8K Hold
14,875
– – ﹤0.01% 141
2024
Q4 		$26.9K Hold
14,875
– – ﹤0.01% 140
2024
Q3 		$18.4K Hold
14,875
– – ﹤0.01% 134
2024
Q2 		$20.8K Hold
14,875
– – ﹤0.01% 127
2024
Q1 		$24.7K Hold
14,875
– – ﹤0.01% 127
2023
Q4 		$24.1K Sell
14,875
-4,000
-21% -$6.03K ﹤0.01% 127
2023
Q3 		$40.6K Buy
+18,875
New +$40.4K 0.01% 125

Greatmark Investment Partners's THTX Position: Q4 2025 in Review

Greatmark Investment Partners sold out of Theratechnologies (THTX) in Q4 2025, closing a stake of 11,250 shares — an estimated $36.1K sold.

Greatmark Investment Partners first reported a position in THTX in Q3 2023 and held it in 9 quarters. The position peaked at $40.6K in Q3 2023. 0 funds tracked by Wall St. Rank hold THTX as of Q4 2025.

  • Greatmark Investment Partners reported no remaining Theratechnologies position as of Q4 2025 after selling out during the quarter.
  • Greatmark Investment Partners sold 11,250 Theratechnologies shares in Q4 2025, an estimated $36.1K.
  • Greatmark Investment Partners first reported a position in Theratechnologies in Q3 2023 and held it in 9 quarters.
  • Greatmark Investment Partners's Theratechnologies position peaked at $40.6K in Q3 2023.
  • 0 funds tracked by Wall St. Rank held Theratechnologies as of Q4 2025.

Based on Greatmark Investment Partners's 13F filing for Q4 2025, filed 27 Jan 2026.